Weekly Yoga Classes
BehavioralAll participants are invited to attend weekly yoga classes.
NCT Number: NCT04641221
Phase 2 - Multiphase Optimization Strategy (MOST) Optimization Phase:
1. To conduct a factorial experiment that will allow us to evaluate the impact of each of the 4 intervention components on yoga dosage received. We will enroll a total n=192. All participants will receive the core yoga intervention, with random assignment to the four intervention components outlined above. 2. Use results from Phase 2 to choose an efficient combination of intervention components that, together with standard yoga classes, maximizes yoga dosage. 3. Examine mechanisms by which components are hypothesized to work.
Looking for future studies?
Notify Me18 year and older
All sexes
Interventional
Not applicable
Boston Medical Center, Boston, Massachusetts, United States
In Phase 2, we will conduct a fully powered optimization trial. We will enroll 192 participants, planning to role approximately equal numbers of participants in both sites. In both phases, all participants will receive the core yoga intervention (12 weeks of weekly manualized yoga classes), with random assignment to the 4 key intervention components. Participants will be patients enrolled in methadone (MMT) or buprenorphine/naloxone (BUP) treatment with chronic pain. Enrollment period for this phase will last approximately 2 years.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
All participants are invited to attend weekly yoga classes.
Time frame: 3 months
Total minutes per week practicing yoga, including in class and outside of class, assessed weekly via interview
Butler Hospital
Other
Acronym: YOGAMAT-II
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT05351905
Cannabis, Chemically-Induced Disorders
Toronto, Ontario, Canada
View Trial DetailsNCT05286112
Behavior, Behavioral Symptoms
Canandaigua, New York, United States
View Trial DetailsNCT07194928
Chronic Pain, Neurologic Manifestations
Philadelphia, Pennsylvania, United States
View Trial DetailsNCT03485430
Analgesics, Opioid, Chemically-Induced Disorders
Lund, Skåne County, Sweden
View Trial Details